These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19450119)

  • 21. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation criteria for bronchial carcinoma. Economic criteria in the management of lung cancer].
    Chouaid C
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S118-16S122. PubMed ID: 17268348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral chemotherapy for colorectal cancer: some economic considerations.
    Saltz L
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):29-32. PubMed ID: 11219974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Quality of life in patients with colorectal cancer].
    Conroy T; Rauch P; Guillemin F
    Gastroenterol Clin Biol; 1999 Apr; 23(4):489-501. PubMed ID: 10416113
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy for operable and advanced colorectal cancer.
    Aschele C; Bergamo F; Lonardi S
    Cancer Treat Rev; 2009 Oct; 35(6):509-16. PubMed ID: 19481872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement.
    Ziogas DC; Zintzaras E
    Ann Epidemiol; 2009 Jul; 19(7):494-500. PubMed ID: 19523596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapy and hepatectomy for liver metastasis from colorectal cancer].
    Ohkubo T; Takayama T
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1247-52. PubMed ID: 19692762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.
    Machado M; Cruz LS; Tannus G; Fonseca M
    Clin Ther; 2009 May; 31(5):962-79. PubMed ID: 19539097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From silos to a critical path of new agent development: a paradigm to revolutionize clinical research.
    Benson AB
    J Clin Oncol; 2008 Apr; 26(12):1924-5. PubMed ID: 18421045
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent developments in adjuvant chemotherapy for colorectal cancer.
    Knowles GH; Jodrell DI
    Eur J Cancer Care (Engl); 1997 Mar; 6(1):18-22. PubMed ID: 9238925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronomodulated chemotherapy for colorectal cancer: failing the test of time?
    Takimoto CH
    Eur J Cancer; 2006 Mar; 42(5):574-81. PubMed ID: 16439112
    [No Abstract]   [Full Text] [Related]  

  • 35. Closure of temporary stoma after anterior resection.
    Chand M; Talbot R; Nash G
    Colorectal Dis; 2007 Oct; 9(8):758-9; author reply 759. PubMed ID: 17854295
    [No Abstract]   [Full Text] [Related]  

  • 36. Guidelines for completing the EURONHEED transferability information checklists.
    Nixon J; Rice S; Drummond M; Boulenger S; Ulmann P; de Pouvourville G
    Eur J Health Econ; 2009 May; 10(2):157-65. PubMed ID: 18618158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of alternative adjuvant chemotherapy modalities for colorectal carcinoma.
    Tierney WM; Fendrick AM
    J Clin Gastroenterol; 1996 Dec; 23(4):248-50. PubMed ID: 8957724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Costs, disease management and DRG].
    Barni S; Mandalà M; Gambera M
    Tumori; 2001; 87(1 Suppl 1):S59. PubMed ID: 11300029
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel targets for systemic therapy of colorectal cancer.
    Kopetz S
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):38-40. PubMed ID: 18322439
    [No Abstract]   [Full Text] [Related]  

  • 40. [Economic effects of "molecular" medicine].
    Riemann JF
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1740. PubMed ID: 17713881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.